DoH policies Equality Screened 1 April to 30 June 2015

In fulfilling its commitments within its Equality Scheme the Department equality screens policies to assess the impact and determine if a full Equality Impact Assessment (EQIA) is required

Documents

Amendments to Controlled Drugs Regulations Northern Ireland 2009
PDF (588 KB)

A Safeguarding Policy for Children and Young People in Northern Ireland
PDF (289 KB)

NICE Clinical Guideline CG61 Irritable bowel syndrome in adults: diagnosis and management of irritable bowel syndrome in primary care – Addendum
PDF (150 KB)

NICE Guidelines NG3 - Diabetes in pregnancy: management of diabetes and its complications from preconception to the postnatal period - This guideline updates and replaces NICE guideline CG63
PDF (146 KB)

NICE (Clinical) Guidelines NG5 - Medicines optimisation: the safe and effective use of medicines to enable the best possible outcomes
PDF (152 KB)

NICE Guidance NG6 - Excess winter deaths and morbidity and the health risks associated with cold homes
PDF (161 KB)

NICE (Public Health) Guidelines NG7 - Maintaining a healthy weight and preventing excess weight gain among adults and children
PDF (154 KB)

NICE Guidance PH49 - Behaviour change: individual approaches
PDF (141 KB)

NICE Technology Appraisal TA330 - Sofosbuvir for treating chronic hepatitis C
PDF (137 KB)

NICE Technology Appraisal TA 335 - Rivaroxaban for preventing adverse outcomes after acute management of acute coronary syndrome
PDF (142 KB)

NICE Technology Appraisal TA 336 - Empagliflozin in combination therapy for treating type 2 diabetes
PDF (144 KB)

NICE Technology Appraisal TA 337 - Rifaximin for maintaining remission from episodes of hepatic encephalopathy
PDF (135 KB)

NICE Technology Appraisal TA 338 - Pomalidomide for treating relapsed and refractory multiple myeloma previously treated with both lenalidomide and bortezomib
PDF (139 KB)

NICE Technology Appraisal TA339 - Omalizumab for treating previously treated chronic spontaneous urticaria
PDF (135 KB)

NICE Technology Appraisal TA340 - Ustekinumab for treating active psoriatic arthritis (Rapid Review of TA313)
PDF (143 KB)

NICE Technology Appraisal TA 341 - Apixaban for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism
PDF (138 KB)

NICE Technology Appraisal TA342 - Vedolizumab for treating moderately to severely active ulcerative colitis
PDF (137 KB)

NICE Technology Appraisal TA343 - Obinutuzumab in combination with chlorambucil for untreated chronic lymphocytic leukaemia
PDF (142 KB)

NICE Technology Appraisal TA344 - Ofatumumab in combination with chlorambucil or bendamustine for previously untreated chronic lymphocytic leukaemia
PDF (139 KB)

Service Framework for Respiratory Health and Wellbeing
PDF (404 KB)

Help viewing documents